Acadian Asset Management LLC Eli Lilly & CO Transaction History

Acadian Asset Management LLC

$32.2 Billion
Q3 2024

A detailed history of Acadian Asset Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Acadian Asset Management LLC holds 63,163 shares of LLY stock, worth $49.2 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

63,163

Previous 78,428 19.46%

Holding current value

$49.2 Million

Previous $71 Million 21.19%

% of portfolio

0.17%

Previous 0.22%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $11.8 Million - $14.7 Million	-15,265 Reduced 19.46%	63,163 $56 Million
Q2 2024 Aug 06, 2024	BUY	$724.87 - $909.04 $30.1 Million - $37.8 Million	41,531 Added 112.56%	78,428 $71 Million
Q1 2024 May 10, 2024	BUY	$592.2 - $792.28 $1.36 Million - $1.81 Million	2,289 Added 6.61%	36,897 $28.7 Million
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $7.93 Million - $9.35 Million	-15,107 Reduced 30.39%	34,608 $20.2 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $2.84 Million - $3.91 Million	6,528 Added 15.12%	49,715 $26.7 Million
Q2 2023 Aug 07, 2023	BUY	$350.74 - $468.98 $590,646 - $789,762	1,684 Added 4.06%	43,187 $20.3 Million
Q1 2023 May 11, 2023	SELL	$310.63 - $364.82 $503,841 - $591,738	-1,622 Reduced 3.76%	41,503 $14.2 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $422,838 - $492,691	1,315 Added 3.15%	43,125 $15.8 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $2.75 Million - $3.14 Million	9,291 Added 28.57%	41,810 $13.5 Million
Q2 2022 Aug 09, 2022	SELL	$278.73 - $327.27 $1.98 Million - $2.32 Million	-7,086 Reduced 17.89%	32,519 $10.5 Million
Q1 2022 May 12, 2022	SELL	$234.69 - $291.66 $2.13 Million - $2.65 Million	-9,080 Reduced 18.65%	39,605 $11.3 Million
Q4 2021 Feb 10, 2022	BUY	$224.85 - $279.04 $2.68 Million - $3.33 Million	11,936 Added 32.48%	48,685 $13.4 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $3.57 Million - $4.39 Million	-16,095 Reduced 30.46%	36,749 $8.49 Million
Q2 2021 Aug 11, 2021	SELL	$180.55 - $233.54 $93.6 Million - $121 Million	-518,157 Reduced 90.75%	52,844 $12.1 Million
Q1 2021 May 11, 2021	SELL	$164.32 - $212.72 $49.8 Million - $64.4 Million	-302,814 Reduced 34.65%	571,001 $107 Million
Q4 2020 Feb 11, 2021	BUY	$130.46 - $172.63 $41.1 Million - $54.4 Million	315,063 Added 56.39%	873,815 $148 Million
Q3 2020 Nov 09, 2020	BUY	$146.22 - $169.13 $50.9 Million - $58.9 Million	348,036 Added 165.17%	558,752 $82.7 Million
Q2 2020 Aug 12, 2020	BUY	$136.42 - $164.18 $24.4 Million - $29.4 Million	179,182 Added 568.22%	210,716 $34.6 Million
Q1 2020 May 11, 2020	BUY	$119.05 - $147.35 $2.75 Million - $3.4 Million	23,098 Added 273.8%	31,534 $4.37 Million
Q4 2019 Feb 06, 2020	BUY	$106.92 - $132.43 $694,124 - $859,735	6,492 Added 333.95%	8,436 $1.11 Million
Q3 2019 Nov 07, 2019	SELL	$106.79 - $116.16 $356,785 - $388,090	-3,341 Reduced 63.22%	1,944 $217,000
Q2 2019 Aug 08, 2019	SELL	$110.79 - $129.32 $2.02 Million - $2.36 Million	-18,228 Reduced 77.52%	5,285 $586,000
Q1 2019 May 09, 2019	SELL	$111.31 - $131.02 $6.52 Million - $7.67 Million	-58,565 Reduced 71.35%	23,513 $3.05 Million
Q4 2018 Feb 07, 2019	SELL	$105.9 - $118.64 $13.3 Million - $14.9 Million	-126,007 Reduced 60.56%	82,078 $9.5 Million
Q3 2018 Oct 30, 2018	BUY	$85.86 - $107.31 $15.3 Million - $19.1 Million	177,876 Added 588.82%	208,085 $22.3 Million
Q2 2018 Jul 24, 2018	SELL	$75.7 - $86.88 $2.83 Million - $3.24 Million	-37,343 Reduced 55.28%	30,209 $2.58 Million
Q1 2018 Apr 12, 2018	BUY	$74.21 - $87.6 $5.01 Million - $5.92 Million	67,552 New	67,552 $5.23 Million
Q4 2017 Jan 18, 2018	SELL	$81.94 - $87.89 $1.08 Million - $1.15 Million	-13,141 Closed	0 $0
Q3 2017 Oct 13, 2017	BUY	$77.07 - $85.54 $1.01 Million - $1.12 Million	13,141	13,141 $1.12 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $740B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Account

Acadian Asset Management LLC Eli Lilly & CO Transaction History